New Allergan Patents May Fend Off Restasis Rivals

By | December 20, 2013

Scalper1 News

Allergan (AGN) reportedly obtained new patents for its Restasis eye drops, sending shares up sharply for the second day in a row on the stock market today. Although the company itself made no announcement, word started to go around Thursday that three patent applications the company filed in August had been granted and will appear in the next Orange Book. This is significant because the earlier composition patent on the product is due to expire in Scalper1 News

Scalper1 News